April 2017 - Page 5 of 6 - NetworkNewsWire

FridayApr 07, 2017 12:06 pm

Marina Biotech, Inc. (MRNA) Sets Further Development of Drug Candidates IT-102 and IT-103, Signs Windlas Healthcare Manufacturing Agreement

Marina Biotech Inc. (OTCQB: MRNA) filed a 10K with the SEC on April 5, 2017, for its year ended December 31, 2016. The late stage biopharmaceutical company summarized its achievements in 2016 and provided an outlook into its 2017 performance, including its planned clinical trials in 2018. Marina Biotech specializes in creating and commercializing innovative therapies for treatments of cancer, hypertension, and arthritis. The firm plans to move by the first quarter of 2018 into a phase 3 clinical study of its drug candidate, IT-102, a fixed dose combination (FDC) bi-layer tablet, said Joseph Ramelli, chief executive officer of Marina…

FridayApr 07, 2017 9:21 am

India Globalization Capital, Inc. (NYSE: IGC) at the Forefront of Innovation Thanks to Strategic Alliances

How does a company in the mining industry successfully move toward becoming a leader in the marijuana sector, specifically cannabinoid-based pharmaceutical therapies that treat a variety of diseases and conditions? In the case of India Globalization Capital, Inc. (NYSE MKT: IGC), the answer is creative management’s ability to identify opportunity, coupled with a relentless drive toward innovation. IGC made its switch to the marijuana industry after its CEO, Executive Chairman, and President Ram Mukunda was unafraid to recognize and act on a need for the company to make a positive and swift switch to a stronger and more lucrative market.…

ThursdayApr 06, 2017 3:20 pm

CytoDyn Inc. (CYDY) Pioneering New Weapons in the War against HIV

The scourge of HIV/AIDS surged to the forefront of American consciousness in 1980 when the first case was reported to the Centers for Disease Control and Prevention. Initially thought to be transmitted solely through homosexual liaisons, it was soon realized that the disease could be passed through the bodily fluids of any person infected with the human immunodeficiency virus (HIV). Contrary to early myths, HIV cannot be contracted by shaking hands or hugging, or by touching dishes or toilet seats used by infected people. It doesn’t spread through the air, through insect bites or through sweat, saliva or urine. HIV…

ThursdayApr 06, 2017 1:01 pm

InMed Pharmaceuticals, Inc. (IMLFF) Adds to Its Drug Development Pipeline

A pre-clinical stage biopharmaceutical company, InMed Pharmaceuticals, Inc. (OTCQB: IMLFF) has revealed two additions to its drug development pipeline. An expedited drug development timeline is now in place for INM-750 for epidermolysis bullosa (EB), with a potential market of about $1 billion. The disease is characterized by fragile skin in children. The company has also announced the development of INM-085 for glaucoma, which represents a potential global market of over $5 billion. Resulting in a defect in the connective tissue between the dermis and epidermis, most often caused by a lack of keratins, EB currently has no medication-based treatments. Multiple…

ThursdayApr 06, 2017 11:33 am

SinglePoint, Inc. (SING) Set to Capitalize on Congressional Push to Regulate and Tax Marijuana

The U.S. Congress in March introduced legislation to regulate and tax marijuana and to remove it from the federal Controlled Substances Act. The move (http://nnw.fm/Qi81t) would effectively end cannabis prohibition and allow it to be regulated in a way alcohol has been since 1933. This move would be highly beneficial for SinglePoint, Inc. (OTC: SING), a leading mobile technology and payment solutions company that provides ancillary services to the marijuana industry. Legislation was introduced by Sen. Ron Wyden (D-OR) and Rep. Jared Polis (D-CO). It would allow the states to choose to legalize cannabis at their discretion. Also, federal regulations…

ThursdayApr 06, 2017 8:30 am

Global Oncology Market Gains Ground, Driven by Innovative Cancer Treatment Therapies

Survival rates for several major cancers have steadily improved over the last couple of decades, according to the American Cancer Society (ACS). Still, an annual report estimates there will be nearly 1.7 million new cancer cases in 2017, and close to 700,000 deaths from the disease in the United States. While early detection and the reduction of certain risk factors play a role in increased survival rates, so does the application of innovative therapies. TapImmune, Inc. (NASDAQ: TPIV) (TPIV Profile), Pfizer Inc. (NYSE: PFE), Celgene Corporation (NASDAQ: CELG), Bristol-Myers Squibb Company (NYSE: BMY) and Clovis Oncology, Inc. (NASDAQ: CLVS) are…

WednesdayApr 05, 2017 3:30 pm

ChineseInvestors.com, Inc. (CIIX) Combating Alzheimer’s Disease through Development of CBD Health Products

China’s growing economy has proven to be beneficial to many across the country. Some of these benefits include higher living standards, better health and nutrition, and longer life expectancy. Unfortunately, China’s longer-lived population has resulted in a significant increase in the number of people having to care for seniors with various mental dysfunctions, most notably dementia and, in particular, Alzheimer’s disease. Alzheimer’s is a neurodegenerative type of dementia that is most prominent in elderly people. The disease is a disorder that involves the death of brain cells leading to various cases of memory loss and cognitive decline. The disease starts…

WednesdayApr 05, 2017 2:12 pm

eXp World Holdings, Inc. (EXPI) Projects Agent/Broker Count Will Rise To 5,500-6,500 By Year End 2017

In its recent presentation at the MicroCap Conference in New York, eXp World Holdings, Inc. (OTCQB: EXPI) projected that its count of agents/brokers would be in the range of 5,500-6,500 by the end of this year, according to Glenn Sanford, CEO and company founder. eXp World Holdings is the holding company for eXp Realty LLC and eXp Realty of Canada, Inc. Through these subsidiaries, EXPI operates as a unique 24/7 cloud-based brokerage company that enables agents to earn company stock through production and offers them a percentage of gross commissions earned by other agents they attract into the company. eXp…

WednesdayApr 05, 2017 8:30 am

Marijuana Market Offers Variety of Investment Options and Consistent, Long-Lasting Growth Potential

With the North American cannabis market boasting an estimated worth of $7.2 billion in 2016, and new reports projecting CAGR of between 17 percent and 25 percent within the next few years, it's certainly an exciting time to invest in the marijuana market. Investment opportunities are abundant and diverse with companies like SinglePoint, Inc. (SING) (SING Profile), Innovative Industrial Properties Inc. (IIPR), Insys Therapeutics Inc. (INSY), MassRoots Inc. (MSRT) and Axim Biotechnologies Inc. (AXIM). The marijuana market is on fire for more reasons than one. First, there's the huge potential for financial growth. A recent report from New Frontier Data…

TuesdayApr 04, 2017 2:44 pm

Moxian, Inc. (NASDAQ: MOXC) Set to Become an Industry Leader for the Future of Commerce

Fast-developing consumerism in China is giving us a glimpse as to what is working and what could shape our future commerce habits worldwide. Currently, the mobile and social revolutions are taking over the commerce world, a process that is expected to accelerate. According to Statista (http://nnw.fm/ottB9), the number of smartphone users is expected to go from 2.1 billion in 2016 to 2.87 billion by the end of 2020, leading to a potentially huge surge in the number of consumers shopping on their phones. Most importantly, this sector is being led by China, which CNBC says accounts for approximately 30% of…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

Month: April 2017